Aligos Therapeutics Inc. (ALGS) Tops Q2 EPS by 101c
Tweet
Share
E-mailGet Alerts ALGS Hot Sheet
Join SI Premium – FREE
Aligos Therapeutics Inc. (NASDAQ: ALGS) reported Q2 EPS of ($0.14), $1.01 better than the analyst estimate of ($1.15).
For earnings history and earnings-related data on Aligos Therapeutics Inc. (ALGS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- LogicBio Therapeutics (LOGC) Misses Q2 EPS by 10c
- Birchtech Corp. (BCHT) Misses Q2 EPS by 7c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
